| 1. intrathecal.af.
2. Infusions, Intraspinal/
3. Infusion Pumps, Implantable/
4. infusion pump$.af.
5. injection$.af.
6. infusion$.af.
7. Infusion Devices, Intermittent/
8. continuous infusion$.af.
9. Infusions, Parenteral/
10. infusion rates/
11. Injections, Intraspinal/
12. Neurosurgery/
13. bolus.af.
14. or/1‐13
15. baclofen.af.
16. baclofen/
17. muscle relaxants, central/
18. aminobutyric acid$.af.
19. Aminobutyric Acids/
20. GABA.af.
21. GABA/
22. or/15‐21
23. spastic$.af.
24. Muscle Spasticity/
25. exp Muscle Hypertonia/
26. hypertoni$.af.
27. "Range of Motion"/
28. muscle contraction/
29. Muscle Tonus/
30. muscle spasm$.af.
31. Spasm/
32. ashworth score.af.
33. PEDI.af.
34. Physical Therapy Assessment/
35. Occupational Therapy Assessment/
36. GMFM$.af.
37. Functional Assessment/
38. Motor Skills/
39. Treatment Outcomes/
40. exp locomotion/
41. exp "Activities of Daily Living"/
42. or/23‐41
43. cerebral palsy.af.
44. Cerebral Palsy/
45. 43 or 44
46. 14 and 22 and 42 and 45
47. randomized controlled trial$.mp.
48. exp randomized controlled trials/
49. random allocation$.mp.
50. controlled clinical trials.mp.
51. clinical trial.pt.
52. exp clinical trials/
53. (clin$ adj5 trial$).tw.
54. double blind method$.mp.
55. single blind method$.mp.
56. ((singl$ or doubl$ or trebl$ or tripl$) adj5 (blind$ or mask$)).tw.
57. placebos/
58. placebo$.tw.
59. random.tw.
60. exp research design/
61. exp follow up studies/
62. exp evaluation studies/
63. exp prospective studies/
64. retrospective design/
65. retrospective panel studies/
66. exp case control studies/
67. comparative study/
68. cross‐sectional studies/
69. (control$ or prospectiv$ or volunteer$).tw.
70. or/47‐69
71. 46 and 70
72. limit 71 to (infant <1 to 23 months> or preschool child <2 to 5 years> or child <6 to 12 years> or adolescence <13 to 18 years>)
73. limit 72 to "review"
74. 72 not 73 |
